Search Within

Benjamin Heath Durham

  1. "2023"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. Hematologic Malignancies, Division of (13)
  4. Executive Committee, Center for Hematologic Malignancies (11)
  5. GSK Faculty (11)
  6. Tow Center for Developmental Oncology (TCDO) (11)

More Groups

People
  1. Omar Abdel-Wahab (11)
  2. Eli Diamond (10)
  3. Mariko Yabe (9)
  4. Kseniya Petrova-Drus (8)
  5. Mario Lacouture (6)
  6. Veronica Rotemberg (6)

More People

Years
  1. 2023 (13)
Publications
  1. Blood (3)
  2. Pediatric Blood and Cancer (3)
  3. Blood Advances (2)
  4. British Journal of Haematology (1)
  5. Clinical Cancer Research (1)
  6. Journal of Molecular Diagnostics (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Wiley Periodicals, Inc (3)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. John Wiley & Sons (1)
  6. Massachusetts Medical Society (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society
    Meeting Abstract

    Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • DNA methylation-based classification of hairy cell leukemia and splenic B cell lymphoma
    Meeting Abstract

    Yamaguchi, K.; Abdelbaky, S.; Arons, E.; Cross, M.; Wu, Y. Z.; Weigel, C.; Anghelina, M. I.; Parker, H.; Kibler, A.; Salido, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type
    Research Letter

    Emile, J. F.; Hélias-Rodzewicz, Z.; Durham, B. H.; Héritier, S.; da Silva, M.; Younas, K.; Cohen-Aubart, F.; Abdel-Wahab, O.; Diamond, E. L.; Donadieu, J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Hershkovitz-Rokah, O.; Abdel-Wahab, O.; Yabe, M.; Chung, Y. R.; Itchaki, G.; Ben-Sasson, M.; Asher-Guz, V. A.; Groshar, D.; Doe-Tetteh, S. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
    Research Letter

    Diamond, E. L.; Francis, J. H.; Lacouture, M. E.; Rotemberg, V.; Yabe, M.; Petrova-Drus, K.; Ulaner, G. A.; Reddy, R.; Abdel-Wahab, O.; Durham, B. H.
    Leukemia (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clonal characterization and somatic hypermutation assessment by next-generation sequencing in chronic lymphocytic leukemia/small lymphocytic lymphoma: A detailed description of the technical performance, clinical utility, and platform comparison
    Journal Article

    Petrova-Drus, K.; Syed, M.; Yu, W.; Hutt, K.; Zlotnicki, A. M.; Huang, Y.; Kamalska-Cyganik, M.; Maciag, L.; Wang, M.; Ma, Y. G.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save